Osimertinib + Anti Platelet Agents Interaction
Moderateinteraction on record
Description
Osimertinib increases substrate exposure, potentially increasing toxicity risk. Monitor for adverse reactions of the substrate.
Mechanism
Osimertinib inhibition of BCRP or P-gp increases substrate exposure
Source: NLP:osimertinib